Diagnostic delay of malignant melanoma due to the corona-pandemic

Recruiting

• Conditions: C43.9; Malignant melanoma of skin, unspecified

• Registration Number: DRKS00030310
• Lead Sponsor: Klinik für Dermatologie Klinikum Nürnberg, Standort Nord

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-01-10
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 2800

Inclusion Criteria

all patients of the skincancer-center Nuerenberg that with the diagnose of malignant melanoma in the years 2012 until march 2021

Exclusion Criteria

patients who are diganosed with two or more malignant melanoma were excluded

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
tumor thickness

Secondary Outcome Measures

Name	Time	Method
AJCC, ICD-10, gender, ulceration, questionnaire for qualitative characteristics (possible reasons for a delay in diagnosis), date of the initial diagnosis